Literature DB >> 21469117

Selective effects of NF-κB1 deficiency in CD4⁺ T cells on Th2 and TFh induction by alum-precipitated protein vaccines.

Karine Serre1, Elodie Mohr, Cécile Bénézech, Roger Bird, Mahmood Khan, Jorge H Caamaño, Adam F Cunningham, Ian C M Maclennan.   

Abstract

NF-κB1-dependent signaling directs the development of CD4(+) Th2 cells during allergic airway inflammation and protective responses to helminth infection. Here, we show that IL-4 and IL-13 production is NF-κB1-dependent in mouse OVA-specific CD4(+) (OTII) T cells responding to alum-precipitated OVA (alumOVA) immunization. More surprisingly, we found that NF-κB1 deficiency in OTII cells also selectively impairs their CXCR5 induction by alumOVA without affecting upregulation of BCL6, IL-21, OX40 and CXCR4 mRNA and PD-1 protein. This results in functional impairment of follicular helper T cells. Thus, fewer germinal center B cells develop in LN responses to alumOVA in T-cell-deficient mice reconstituted with NF-κB1(-/-) OTII cells as opposed to NF-κB1(+/+) OTII cells, while plasma cell numbers are comparable. Unlike CXCR5 induction in CD4(+) T cells, NF-κB1-deficient recirculating follicular B cells are shown to express normal levels of CXCR5. The selective effects of NF-κB1-deficiency on Th2 and follicular helper T cell induction do not appear to be due to altered expression of the Th2-associated transcription factors - GATA-3, c-Maf and Ikaros. Altogether, these results suggest that NF-κB1 regulates the expression of CXCR5 on CD4(+) T cells primed in vivo, and thus selectively controls the T-cell-dependent germinal center component of B-cell response to alumOVA.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21469117     DOI: 10.1002/eji.201041126

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.

Authors:  Eun-Ju Ko; Youri Lee; Young-Tae Lee; Yu-Jin Jung; Vu L Ngo; Min-Chul Kim; Ki-Hye Kim; Bao-Zhong Wang; Andrew T Gewirtz; Sang-Moo Kang
Journal:  Vaccine       Date:  2019-05-14       Impact factor: 3.641

Review 2.  Old and new adjuvants.

Authors:  Amy S McKee; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2017-07-19       Impact factor: 7.486

Review 3.  Bcl6-Mediated Transcriptional Regulation of Follicular Helper T cells (TFH).

Authors:  Jinyong Choi; Shane Crotty
Journal:  Trends Immunol       Date:  2021-03-01       Impact factor: 16.687

4.  IL-4-secreting secondary T follicular helper (Tfh) cells arise from memory T cells, not persisting Tfh cells, through a B cell-dependent mechanism.

Authors:  Keke C Fairfax; Bart Everts; Eyal Amiel; Amber M Smith; Gabriele Schramm; Helmut Haas; Gwendalyn J Randolph; Justin J Taylor; Edward J Pearce
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

Review 5.  NF-κB: roles and regulation in different CD4(+) T-cell subsets.

Authors:  Hyunju Oh; Sankar Ghosh
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

6.  Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.

Authors:  Eun-Ju Ko; Young-Tae Lee; Ki-Hye Kim; Yu-Jin Jung; Youri Lee; Timothy L Denning; Sang-Moo Kang
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

7.  Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells in vivo independently of Foxp3 expression.

Authors:  Karine Serre; Cécile Bénézech; Guillaume Desanti; Saeeda Bobat; Kai-Michael Toellner; Roger Bird; Susan Chan; Philippe Kastner; Adam F Cunningham; Ian C M Maclennan; Elodie Mohr
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240

8.  The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.

Authors:  Tirth Raj Ghimire
Journal:  Springerplus       Date:  2015-04-16

9.  Mechanism of immunopotentiation and safety of aluminum adjuvants.

Authors:  Harm Hogenesch
Journal:  Front Immunol       Date:  2013-01-10       Impact factor: 7.561

10.  End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression.

Authors:  Ruijing Zhang; Jason Saredy; Ying Shao; Tian Yao; Lu Liu; Fatma Saaoud; William Y Yang; Yu Sun; Candice Johnson; Charles Drummer; Hangfei Fu; Yifan Lu; Keman Xu; Ming Liu; Jirong Wang; Elizabeth Cutler; Daohai Yu; Xiaohua Jiang; Yafeng Li; Rongshan Li; Lihua Wang; Eric T Choi; Hong Wang; Xiaofeng Yang
Journal:  Redox Biol       Date:  2020-02-20       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.